/ACOU.ST
ACOU.ST Stock - AcouSort AB (publ)
Healthcare|BiotechnologySTO
$2.64-0.75%
$0.02 (-0.75%) • Dec 23
59
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.90
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACOU.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.61 – $2.67
TARGET (TP)$3.04
STOP LOSS$2.43
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.20
52W High$13.05
52W Low$2.07
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.74M | $10.55M | $4.96M | $3.01M | $4.93M |
| Gross Profit | $4.77M | $8.39M | $2.91M | $548,000 | $3.04M |
| Gross Margin | 100.7% | 79.5% | 58.7% | 18.2% | 61.6% |
| Operating Income | $-16,126,000 | $-17,487,000 | $-14,349,000 | $-12,154,000 | $-7,814,000 |
| Net Income | $-15,078,000 | $-17,089,000 | $-13,211,000 | $-12,381,000 | $-8,220,000 |
| Net Margin | -318.3% | -162.0% | -266.2% | -411.7% | -166.8% |
| EPS | $-1.01 | $-1.29 | $-1.00 | $-0.93 | $-0.70 |
Company Overview
AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company was founded in 2010 and is based in Lund, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACOU.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.12
Q4 2025
EPS Surprise History
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 26, 2025 | — | $-0.12 | — | — |
Q2 2025 | May 28, 2025 | — | $-0.26 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-0.19 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.25 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.32 | — | — |
Q2 2024 | Apr 24, 2024 | — | $-0.49 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.25 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.32 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.24 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.22 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.18 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.32 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.31 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.19 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.27 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.31 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.31 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.15 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.29 | — | — |
Q4 2020 | Nov 25, 2020 | — | $-0.12 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ACOU.ST
What is ACOU.ST's current stock price?
AcouSort AB (publ) (ACOU.ST) is currently trading at $2.64 per share. The stock has moved -0.75% today.
What is the analyst price target for ACOU.ST?
No analyst price targets are currently available for this stock.
What sector is AcouSort AB (publ) in?
AcouSort AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is ACOU.ST's market cap?
AcouSort AB (publ) has a market capitalization of $0.06 billion, making it a small-cap company.
Does ACOU.ST pay dividends?
No, AcouSort AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATORX.ST
Alligator Bioscience AB (publ)
$0.34
Mkt Cap: $0.0B
EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ)
$16.92
Mkt Cap: $0.0B
LPGO.ST
Lipigon Pharmaceuticals AB (publ)
$0.01
Mkt Cap: $0.0B
MODTX.ST
Modus Therapeutics Holding AB (publ)
$0.30
Mkt Cap: $0.0B
NEWBRY.ST
Newbury Pharmaceuticals AB (publ)
$1.22
Mkt Cap: $0.0B
ONCOZ.ST
OncoZenge AB (publ)
$6.55
Mkt Cap: $0.1B
ORTI-B.ST
Ortivus AB (publ)
$1.21
Mkt Cap: $0.1B
SIMRIS-B.ST
Simris Alg AB (publ)
$0.05
Mkt Cap: $0.0B
SPAGO.ST
Spago Nanomedical AB (publ)
$0.10
Mkt Cap: $0.0B
SPRINT.ST
Sprint Bioscience AB (publ)
$1.45
Mkt Cap: $0.2B
Explore stocks similar to ACOU.ST for comparison